BNGO - Bionano Genomics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue12,000.7359,505.0436,792.789
Cost of Revenue8,711.3266,030.5123,578.692
Gross Profit3,289.4093,474.5313,214.097
Operating Expenses
Research Development9,484.16312,009.1711,431.941
Selling General and Administrative14,220.33114,079.65812,950.572
Non Recurring---
Others---
Total Operating Expenses32,415.8232,119.3427,961.205
Operating Income or Loss-20,415.085-22,614.297-21,168.416
Income from Continuing Operations
Total Other Income/Expenses Net1,934.204-732.5152,332.725
Earnings Before Interest and Taxes-20,415.085-22,614.297-21,168.416
Interest Expense-1,381.024-590.927-470.072
Income Before Tax-18,480.881-23,346.812-18,835.691
Income Tax Expense15.51118.55212.924
Minority Interest---
Net Income From Continuing Ops-18,496.392-23,365.364-18,848.615
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,496.392-23,365.364-18,848.615
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,496.392-23,365.364-18,848.615